跳至主要内容
临床试验/NCT02120599
NCT02120599已完成不适用

Randomized Controlled Trial of the Impact of Treating Moderately Malnourished Women in Pregnancy

Washington University School of Medicine2 个研究点 分布在 1 个国家目标入组 1,867 人开始时间: 2014年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,867
试验地点
2
主要终点
Maternal change in mid-upper arm circumference (MUAC)

研究概览

简要总结

Malnutrition during pregnancy is more common in poor women in the developing world due to inadequate dietary intake combined with increased nutrient requirements; pregnancy risk is more consequential than among other demographic groups with increased risk of maternal and infant mortality and the lifelong effects of fetal malnutrition. The benefits of treating moderate malnutrition during pregnancy remain largely undocumented. This study tests the hypothesis that providing either a fortified flour or fortified paste-based supplementary food designed to replete the nutrient deficits during pregnancy will result in improved maternal nutritional recovery rates and higher infant birth weights and lengths. This study is a randomized, controlled clinical trial of 3 supplementary foods in 1800 moderately malnourished Malawian women who are pregnant. Subjects will receive one of 3 food rations: 1) a ready-to-use supplementary food formulated to deliver about 200% of the recommended daily allowance (RDA) of most micronutrients in pregnancy (RUSF-P), 2) corn soy blend with a multiple micronutrient tablet chosen to deliver about 200% of the RDA of most micronutrients (CSB-P) or 3), the standard of care which is a corn soy blend with supplementary iron and folic acid (CSB), delivering between 0-350% of the RDA. Subjects will receive the supplementary food until they recover from MAM. The outcome of the pregnancy and maternal nutritional status will be followed until 3 months after delivery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Pregnant and consenting to study participation and HIV testing (if not already performed)
  • •mid-upper-arm circumference (MUAC) ≤ 23 cm
  • •planning to stay in the area and attend the clinic during pregnancy and for 3 months post partum

排除标准

  • •Pregnancy complications such as gestational diabetes, pre-eclampsia, hypertension
  • •Severe anemia (Hg <7.0 mg/dl)
  • •Severe malnutrition
  • •under 18 years of age
  • •over estimated 35 weeks of gestation

研究组 & 干预措施

corn-soy-blend

Active Comparator

This is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (~357 gm/d CSB).

干预措施: corn-soy blend (Dietary Supplement)

corn-soy-blend + multiple micronutrients

Experimental

The treatment provided to women randomized to this arm of the study includes 200gm/d CSB along with a standard maternal multiple micronutrient tablet, which together provide a comparable amount of energy, protein and micronutrients to the ready-to-use supplemental food. The micronutrient supplement known as the United Nations Children's Emergency Fund (UNICEF) / World Health Organization (WHO) / United Nations University (UNU) international multiple micronutrient preparation (UNIMMAP) is widely available and has been used in many settings worldwide in pregnant women.

干预措施: corn-soy blend (Dietary Supplement)

corn-soy-blend + multiple micronutrients

Experimental

The treatment provided to women randomized to this arm of the study includes 200gm/d CSB along with a standard maternal multiple micronutrient tablet, which together provide a comparable amount of energy, protein and micronutrients to the ready-to-use supplemental food. The micronutrient supplement known as the United Nations Children's Emergency Fund (UNICEF) / World Health Organization (WHO) / United Nations University (UNU) international multiple micronutrient preparation (UNIMMAP) is widely available and has been used in many settings worldwide in pregnant women.

干预措施: UNIMMAP (Dietary Supplement)

ready-to-use supplementary food

Experimental

RUSF-P (ready-to-use supplementary food) provides 750 kcal/d, 20 g protein/d, and 200% of RDA/d for most micronutrients during pregnancy (except for vitamins A, B3, folic acid, minerals iodine, magnesium, and calcium which will remain near 100%)

干预措施: ready-to-use supplementary food (Dietary Supplement)

corn-soy-blend

Active Comparator

This is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (~357 gm/d CSB).

干预措施: folic acid (Dietary Supplement)

corn-soy-blend

Active Comparator

This is the control group for the study, which will receive the Malawi standard of care. The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (~357 gm/d CSB).

干预措施: iron (Dietary Supplement)

结局指标

主要结局

Maternal change in mid-upper arm circumference (MUAC)

时间窗: up to 40 weeks

average change in mid-upper-arm circumference

infant birth weight

时间窗: up to 40 weeks

mean birth weights of infants born to mothers in the study

Proportion recovered from moderate acute malnutrition (MAM)

时间窗: up to 40 weeks

proportion of women who reach mid-upper arm circumference (MUAC) \> 23.5 cm for 2 consecutive visits

premature delivery

时间窗: up to 36 weeks

proportion of infants born prematurely

infant birth length

时间窗: up to 40 weeks

mean birth length of infants born to women in the study

次要结局

  • pregnancy complications(up to 40 weeks)
  • maternal weight gain(up to 40 weeks)
  • infant length at 3 months(3 months)
  • maternal hemoglobin(8 weeks)
  • infant survival at 3 months(3 months)
  • infant weight at 3 months(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验